What is the treatment for a 2-year-old female patient with diarrhea due to Clostridioides difficile (C. diff) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for C. difficile Infection in a 2-Year-Old Female

For a 2-year-old female with diarrhea and positive C. difficile stool test, careful consideration should be given to whether this represents true C. difficile infection (CDI) or colonization, as C. difficile testing should not be routinely performed in children 1-2 years of age unless other infectious or noninfectious causes of diarrhea have been excluded. 1

Diagnostic Considerations

  • High rates of asymptomatic C. difficile colonization occur in children under 2 years of age (elevated in the second year of life, though less than in infants) 1
  • Testing in 1-2 year olds should be avoided unless other causes of diarrhea have been excluded 1
  • By 2-3 years of age, colonization rates fall to adult levels (approximately 1-3%) 1
  • One study found that among 100 children <2 years with diarrhea and positive C. difficile toxin, all had resolution regardless of whether C. difficile-specific therapy was administered 1

Management Approach

Step 1: Determine if treatment is necessary

  • Consider whether this represents true infection versus colonization 1
  • Evaluate for other causes of diarrhea before attributing symptoms to C. difficile 1
  • Look for risk factors that would support true CDI:
    • Recent antibiotic exposure (strongest risk factor) 1
    • Healthcare facility exposure 1
    • Underlying conditions like inflammatory bowel disease or immunocompromising conditions 1

Step 2: If treatment is deemed necessary:

First-line treatment options:

  • Oral vancomycin is recommended as first-line therapy 1, 2
    • Metronidazole is no longer recommended as first-line therapy for adults, though historically was used in pediatric patients 2
  • Fidaxomicin is FDA-approved for children ≥6 months of age with C. difficile-associated diarrhea 3
    • Clinical trials showed good efficacy in pediatric patients with sustained response rates of 68.4% for fidaxomicin versus 50% for vancomycin 3

Step 3: Infection control measures

  • Place patient in a private room with dedicated toilet if hospitalized 1
  • Use gloves and gowns when caring for patients with CDI 1
  • Hand hygiene with soap and water is preferred over alcohol-based products during outbreaks 1
  • Continue contact precautions for at least 48 hours after diarrhea resolves 1

Important Caveats

  • C. difficile can be isolated in >50% of children hospitalized with acute gastroenteritis who have another gastrointestinal pathogen identified 1
  • Avoid repeat testing within 7 days during the same episode of diarrhea 1
  • Do not test asymptomatic patients or perform "test of cure" 1
  • Avoid unnecessary antibiotics, as antibiotic stewardship is key to preventing CDI 2

Special Considerations for This Age Group

  • The 2-year-old age represents a transition point where colonization rates are decreasing but still elevated compared to adults 1
  • The decision to treat should be made after careful consideration of whether the positive test represents true infection versus colonization 1
  • If other causes of diarrhea have been ruled out and the child has risk factors or severe symptoms, treatment may be warranted 1

Remember that supportive care with appropriate hydration and nutrition remains essential regardless of whether antimicrobial therapy is initiated 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clostridioides difficile Infection: Update on Management.

American family physician, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.